NCT04566614View on ClinicalTrials.gov

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

CompletedOBSERVATIONAL

Enrollment

128

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

July 31, 2023

Study Completion Date

January 31, 2025

Conditions

Neoplasm, ColorectalNeoplasm of LungNeoplasm, BladderNeoplasms PancreaticBiliary Tract NeoplasmsGastro Intestinal Stromal Tumour

Interventions

OTHER

ctDNA blood sampling

Screening/baseline blood sample to be analysed for ctDNA

Trial Locations (1)

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT04566614 - Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies | Biotech Hunter | Biotech Hunter